ONC Stock: Price, Earnings History and SEC Filings
BeOne Medicines AG (ONC) last traded at $370.33, down 0.33% on the latest session and up 1.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $2.05 against an analyst estimate of $1.40, a beat of 46.4%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ONC earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 5, 2026 | $2.05 | $1.40 | +46.43% |
| Mar 2026 | May 6, 2026 | $1.96 | $0.73 | +168.49% |
| Dec 2025 | Feb 26, 2026 | $0.58 | $1.60 | -63.75% |
| Sep 2025 | Nov 6, 2025 | $1.09 | $0.72 | +51.39% |
ONC beat the analyst EPS estimate in 3 of its last 4 reported quarters. Source: Nasdaq.
How ONC reacts to earnings
Across its last 8 earnings releases, ONC moved 3.2% on average the next session, in either direction. It rose after 5 of 8 reports.
| Report date | Released | Next-session move |
|---|---|---|
| 2026-08-26 | Before open | -0.15% |
| 2026-08-05 | Before open | +1.40% |
| 2026-05-06 | Before open | +5.32% |
| 2026-04-14 | Before open | +1.43% |
| 2026-02-26 | Before open | -8.48% |
| 2025-11-06 | Before open | +3.41% |
| 2025-08-29 | Before open | +2.72% |
| 2025-08-06 | Before open | -2.84% |
Based on the dates of earnings-release 8-K filings (SEC EDGAR) and daily closing prices (Yahoo Finance). Past reactions do not predict future ones.
ONC financial history
| Fiscal year | Revenue | Net income | Free cash flow | Net margin | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | $5.3B | $287M | $942M | 5.4% | $0.19 |
| 2024 | $3.8B | -$645M | -$633M | -16.9% | $-0.47 |
| 2023 | $2.5B | -$882M | -$1.7B | -35.9% | $-0.65 |
| 2022 | $1.4B | -$2.0B | -$1.8B | -141.5% | $-1.49 |
| 2021 | $1.2B | -$1.5B | -$1.6B | -123.9% | $-1.21 |
| 2020 | $309M | -$1.6B | -$1.4B | -526.1% | $-1.50 |
| 2019 | $428M | -$949M | -$840M | -221.5% | $-1.22 |
| 2018 | $198M | -$674M | -$618M | -339.9% | – |
Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.
Latest SEC filings for ONC
- 8-K · Aug 26, 2026Results of operations, Financial statements and exhibits
- 10-Q · Aug 5, 2026
- 8-K · Aug 5, 2026Results of operations, Financial statements and exhibits
- 8-K · Jun 26, 2026Other events
- 8-K · Jun 11, 2026Officer or director change, Shareholder vote, Financial statements and exhibits
- 8-K · May 15, 2026Other events, Financial statements and exhibits
- 10-Q · May 6, 2026
- 8-K · May 6, 2026Results of operations, Financial statements and exhibits
- DEF 14A · Apr 28, 2026
- 8-K · Apr 14, 2026Results of operations, Financial statements and exhibits
Insider filing activity
ONC insiders filed 11 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ONC news
- 3 Healthcare Stocks To Watch In October 2026Oct 24, 2026 · finance.yahoo.com
- BeOne Medicines (ONC) Could Be 13% Undervalued As ESMO Data Lifts The NarrativeOct 24, 2026 · finance.yahoo.com
- BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026Oct 24, 2026 · finance.yahoo.com
- BeOne Stock Tests Buy Zone With Visions Of 177% Earnings Growth. Watch This Clue.Oct 23, 2026 · finance.yahoo.com
- BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal CancerOct 23, 2026 · finance.yahoo.com
- BeOne Medicines to Announce Third Quarter 2026 Financial Results on November 5Oct 22, 2026 · finance.yahoo.com
- BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026Oct 19, 2026 · finance.yahoo.com
About BeOne Medicines AG
BeOne Medicines AG (ONC) is a US-listed public company on Nasdaq. The SEC classifies its business as Pharmaceutical Preparations. Its fiscal year ends in December.